VISVX | VYRDX | VISVX / VYRDX | |
Total Expense Ratio | 0.19 | 0.86 | 22% |
Annual Report Gross Expense Ratio | 0.19 | 0.89 | 21% |
Fund Existence | 27 years | 9 years | - |
Gain YTD | 2.657 | -20.345 | -13% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 56.4B | 103M | 54,757% |
Annual Yield % from dividends | 1.95 | 2.06 | 95% |
Returns for 1 year | 6.61 | -16.35 | -40% |
Returns for 3 years | 19.23 | -21.07 | -91% |
Returns for 5 years | 76.46 | 8.60 | 889% |
Returns for 10 years | 99.26 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 12.71 | 0.09 | +0.71% |
Saratoga Health & Biotechnology C | |||
GCIFX | 15.43 | 0.05 | +0.33% |
Green Century MSCI Intl Indx Instl | |||
DMCFX | 29.36 | -0.06 | -0.20% |
Invesco Discovery Mid Cap Growth R5 | |||
MUEUX | 39.36 | -0.14 | -0.35% |
MFS Blended Research Core Equity R4 | |||
MIDFX | 61.49 | -0.48 | -0.77% |
Marsico Midcap Growth Focus Instl |